Cargando…
Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice
Antiplatelet drugs are widely utilized in the setting of primary stroke prevention, secondary stroke prevention, and neuroendovascular device-related stroke prevention. These medications are effective in general, although significant variability in drug activity exists between patients. Although thi...
Autores principales: | Bonney, Phillip A., Yim, Benjamin, Brinjikji, Waleed, Walcott, Brian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549574/ https://www.ncbi.nlm.nih.gov/pubmed/30936195 http://dx.doi.org/10.1101/mcs.a003731 |
Ejemplares similares
-
Antiplatelet Resistance and Thromboembolic Complications in Neurointerventional Procedures
por: Oxley, Thomas J., et al.
Publicado: (2011) -
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
por: Yi, Ho Jun, et al.
Publicado: (2019) -
Anesthetic Consideration for Neurointerventional Procedures
por: Joung, Kyung Woon, et al.
Publicado: (2014) -
Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms
por: Meyer, Benjamen M., et al.
Publicado: (2023) -
Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)